Status:
COMPLETED
Melatonin Supplements for Improving Sleep in Individuals With Hypertension
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
National Center for Complementary and Integrative Health (NCCIH)
Office of Dietary Supplements (ODS)
Conditions:
Sleep Disorders
Hypertension
Eligibility:
All Genders
35-65 years
Phase:
PHASE2
Brief Summary
This study will evaluate the effectiveness of treatment with melatonin supplements in improving sleep in individuals with high blood pressure who are taking beta-blockers.
Detailed Description
Hypertension, or high blood pressure, is a condition in which an individual's blood pressure is higher than the normal level. It is estimated that one in three individuals in the United States has hig...
Eligibility Criteria
Inclusion
- Diagnosed with uncomplicated hypertension
- Currently being treated with Atenolol (a beta-blocker)
Exclusion
- History of medical illness other than essential hypertension
- Personal or family history of psychiatric illness
- Current use of any medication other than anti-hypertensive drugs
- Any recent travel across time zones
- History of working various shifts on an irregular basis
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00238108
Start Date
October 1 2005
End Date
August 1 2010
Last Update
November 14 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115